Clinical Trial Update: A Randomized Trial of Antithymocyte Globulin Versus Cyclosporine to Treat the Cytopenia of Myelodysplastic Syndrome [Phase 2]

View source ↗

Summary

This Phase 2 randomized trial comparing antithymocyte globulin to cyclosporine for cytopenia in myelodysplastic syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• Antithymocyte Globulin (anti-thymocyte globulin)
• CYCLOSPORINE (cyclosporine)

Snippet

Sponsor: National Institutes of Health Clinical Center (CC) | Conditions: Hematologic Diseases, Myelodysplastic Syndromes | Phase 2 | Status: COMPLETED